Silicon Valley Capital Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-135,788
Closed -$349K 334
2024
Q2
$349K Buy
+135,788
New +$349K 0.05% 62